RankingsPricing
  1. JP-listed companies
  2. Pharmarise Holdings Corporation
  3. Financials
  4. Total current liabilities

Pharmarise Holdings CorporationJP:2796

Market cap
¥6.4B
P/E ratio
22.6x
SummaryFinancialsHistorySegmentsOwnershipWorkforce
Period EndTotal current liabilities (Million JPY)YoY (%)
May 31, 202511,988+12.16%
May 31, 202410,688+8.67%
May 31, 20239,835+16.02%
May 31, 20228,477-9.74%
May 31, 20219,392-6.42%
May 31, 202010,036+7.37%
May 31, 20199,347-13.20%
May 31, 201810,769+9.88%
May 31, 20179,801-8.71%
May 31, 201610,736+1.05%
May 31, 201510,625+5.07%
May 31, 201410,112

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)